Cardinal Health (CAH) is a Top-Ranked Momentum Stock: Should You Buy?

Cardinal Health (CAH), a global healthcare services and products distributor, is highlighted as a stock to watch, currently holding a Zacks Rank of #3 (Hold) and a VGM Score of B. CAH's shares are up 5.6% over the past four weeks, driven by a Momentum Style Score of B and upward revisions from eight analysts, increasing the fiscal 2025 Zacks Consensus Estimate by $0.18 to $8.12 per share; the company also boasts an average earnings surprise of 10.3%.

Analysis

Cardinal Health (CAH), a global healthcare services and products distributor, presents a nuanced profile according to Zacks Investment Research, holding a Zacks Rank of #3 (Hold) while exhibiting positive momentum and overall financial health indicators. Specifically, CAH has achieved a Momentum Style Score of B and a VGM Score of B. This is supported by a 5.6% increase in its share price over the past four weeks and an average earnings surprise of 10.3%. Furthermore, eight analysts have revised their fiscal 2025 earnings estimates for CAH upwards in the last 60 days, contributing to a $0.18 rise in the Zacks Consensus Estimate to $8.12 per share. The Zacks methodology, as detailed in the article, suggests that stocks with a #3 Rank, when accompanied by A or B Style Scores, can still offer upside potential, leading to the article's suggestion that CAH warrants inclusion on investors' shortlists.

Key Decisions for Investors

• Investors should note Cardinal Health's Zacks Rank #3 (Hold) alongside its favorable B-rated Momentum and VGM Style Scores, positive earnings estimate revisions, and recent 5.6% share price appreciation, placing it on a potential watchlist as per the article's suggestion.
• Continuous monitoring of CAH's Zacks Rank is advisable, as an upgrade to #1 (Strong Buy) or #2 (Buy), combined with its current Style Scores, would signify a stronger investment case based on the outlined methodology.
• For investors considering new positions, the #3 (Hold) rank warrants careful consideration, weighing it against the positive momentum indicators and upward earnings revisions which suggest underlying strength.